剖宫产术的椎管内麻醉与疼痛管理
本文提出剖宫产麻醉与镇痛管理的多项重要考虑,聚焦术中及术后疼痛的患者报告结局。内容涵盖子宫、腹膜与腹壁的神经支配及疼痛通路,不同椎管内麻醉与镇痛方式(硬膜外、腰麻、腰硬联合)的优势、局限与适应证,以及麻醉技术与椎管内药物的选择。文中指出剖宫产术中疼痛发生率约15%,寒战发生率高达50%。
要点
- 剖宫产术中疼痛发生率约15%,寒战发生率高达50%,需多方面的预防措施。
- 腰麻提供最可靠的椎管内阻滞,起效最快但持续时间有限,可通过添加佐剂延长。
- 术前应识别术中疼痛的患者特异性危险因素,以进行充分咨询和个体化策略。
核心结论
- 剖宫产麻醉与镇痛管理需综合考虑患者、产科、手术及麻醉相关因素,以提供安全无痛的体验。
- 产科与麻醉团队之间的沟通是确保麻醉方案针对临床情景个体化的关键。
- 文中提出了关于剖宫产麻醉与镇痛管理的多项重要考虑,聚焦术中及术后疼痛的患者报告结局。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- 剖宫产术中疼痛发生于约15%的剖宫产。
- 寒战发生于高达50%的剖宫产,由热量丢失、体温调节紊乱、心理压力和手术因素等复杂相互作用所致。
- 腰麻提供最可靠的椎管内阻滞,起效最快但持续时间有限,可通过添加佐剂延长。
- 术中及术后疼痛增加相关的因素包括子宫外置、产程中剖宫产、再次剖宫产、使用硬膜外麻醉而非腰麻或腰硬联合麻醉。
- 逐步实施阿片类药物节省的多模式镇痛(如对乙酰氨基酚与非甾体抗炎药联用)及个体化阿片类药物处方方案,已被证明可显著减少住院期间阿片类药物消耗和不必要的阿片类药物处方,而不增加术后疼痛。
关键数值与推荐
- 剖宫产术中疼痛发生率约15%。
- 剖宫产寒战发生率高达50%。
- 腰麻提供最可靠的椎管内阻滞,起效最快但持续时间有限,可通过添加佐剂延长。
- 术中及术后疼痛增加相关的因素包括子宫外置、产程中剖宫产、再次剖宫产、使用硬膜外麻醉而非腰麻或腰硬联合麻醉。
- 逐步实施阿片类药物节省的多模式镇痛(如对乙酰氨基酚与非甾体抗炎药联用)及个体化阿片类药物处方方案,已被证明可显著减少住院期间阿片类药物消耗和不必要的阿片类药物处方,而不增加术后疼痛。
临床怎么用
- 术前识别术中疼痛的患者特异性危险因素(如阿片类药物使用障碍、慢性疼痛、既往创伤性分娩经历、焦虑),以促进充分咨询(如设定预期、避免创伤性情境、纳入共享决策、若椎管内阻滞不充分则提供全身麻醉)和个体化策略。
- 优化跨学科沟通以识别分娩硬膜外镇痛不充分,并在需要产程中剖宫产时允许更换,以及麻醉团队和产科医生在切皮前充分测试椎管内阻滞构成最佳实践。
- 识别与术中及术后疼痛增加相关的产科、手术和麻醉相关因素(如子宫外置、产程中剖宫产、再次剖宫产、使用硬膜外麻醉而非腰麻或腰硬联合麻醉),应促使采取特定方法增强麻醉和术后镇痛(如增强椎管内阿片类药物剂量、延长硬膜外镇痛使用局部麻醉药溶液或重复给予硬膜外吗啡、腹壁阻滞,尤其是当椎管内吗啡无法使用时)。
- 实施逐步的阿片类药物节省多模式镇痛(如对乙酰氨基酚与非甾体抗炎药联用)和剖宫产后个体化阿片类药物处方方案,因为这些已被证明可显著减少住院期间阿片类药物消耗和不必要的阿片类药物处方,而不增加术后疼痛。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optimal neuraxial anesthesia for cesarean delivery requires a thorough understanding of patient, obstetrical, surgical, and anesthesia-related factors which can impact pain during and after cesarean delivery. While not all cesarean deliveries are the same from an obstetrical standpoint, not all anesthetics provide the same degree of anesthetic blockade and postcesarean analgesia; therefore, context is crucial to provide patients with a safe and pain-free experience. Communication between obstetrical and anesthesia teams is key to ensure that the anesthetic approach is tailored to the clinical scenario, particularly if emergency cesarean delivery is needed, and follows best practices for cesarean delivery anesthesia. We propose several important considerations for the management of anesthesia and analgesia for cesarean delivery, focusing on patient-reported outcomes related to intraoperative and postoperative pain. Considerations include: (1) understanding the innervation of the uterus, peritoneum and abdominal wall, and the pain pathways involved with sensations and pain during and after cesarean delivery (eg, visceral sensations such as occurs with uterine manipulation may be very uncomfortable for some patients); (2) understanding the different neuraxial anesthetic and analgesic approaches (eg, epidural, spinal, combined spinal-epidural) with their specific advantages, limitations, and indications (eg, spinal anesthesia provides the most reliable neuraxial block, with the fastest onset but a limited duration, though it can be extended by the addition of adjuvants); (3) selecting the most appropriate anesthetic technique and neuraxial medications (eg, local anesthetics, opioids, adjuvants including alpha2-adrenergic agonists) to prevent, mitigate, manage intraoperative discomfort, and optimize postoperative analgesia; (4) recognizing that intraoperative pain during cesarean delivery occurs in approximately 15% of cesarean deliveries and shivering in up to 50% of cesarean delivery (from a complex interplay of heat loss, disrupted thermoregulation, psychological stress, and surgical factors), necessitating multifaceted prevention approaches; (5) preoperatively identifying patient-specific risk factors for intraoperative pain (eg, opioid use disorder, chronic pain, previous traumatic childbirth experience, anxiety) to promote thorough counseling (eg, setting expectations, avoiding traumatizing circumstances, incorporating shared decision-making, offering general anesthesia if neuraxial block is inadequate) and tailored strategies; (6) optimizing interdisciplinary communication to identify inadequate labor epidural analgesia and allow replacement if intrapartum cesarean delivery becomes indicated, as well as adequate testing of neuraxial block by the anesthesia team and the obstetricians before proceeding with skin incision constitutes best practices; (7) recognizing the obstetric, surgical, and anesthesia-related factors associated with increased intraoperative and postoperative pain (eg, uterine exteriorization, intrapartum cesarean delivery, repeat cesarean delivery, use of an epidural anesthetic rather than a spinal or combined spinal-epidural anesthetic) should prompt specific approaches to enhance anesthesia and postoperative analgesia (eg, enhanced doses of neuraxial opioid, prolonged use of epidural analgesia with local anesthetic solutions or repeated doses of epidural morphine, abdominal wall blocks, particularly if neuraxial morphine could not be used); and (8) implementing stepwise opioid-sparing multimodal analgesia (eg, acetaminophen and nonsteroidal antiinflammatory drugs taken together) and personalized protocols for opioid prescriptions after cesarean delivery, since these have been shown to significantly reduce in-hospital opioid consumption and unnecessary opioid prescription without increasing postoperative pain.
引用
- Landau R, Sultan P. Neuraxial anesthesia and pain management for cesarean delivery. Am J Obstet Gynecol. 2025. PMID: 40888444. doi:10.1016/j.ajog.2025.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。